State of Michigan Retirement System Lowers Stock Holdings in Intuitive Surgical, Inc. $ISRG

State of Michigan Retirement System reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.3% during the first quarter, HoldingsChannel.com reports. The firm owned 104,153 shares of the medical equipment provider’s stock after selling 105,200 shares during the quarter. State of Michigan Retirement System’s holdings in Intuitive Surgical were worth $48,013,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. TFR Capital LLC. raised its position in shares of Intuitive Surgical by 0.9% in the 1st quarter. TFR Capital LLC. now owns 7,465 shares of the medical equipment provider’s stock worth $3,441,000 after purchasing an additional 68 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Intuitive Surgical by 11.8% in the first quarter. Principal Financial Group Inc. now owns 615,749 shares of the medical equipment provider’s stock worth $283,854,000 after buying an additional 64,877 shares in the last quarter. Chicago Partners Investment Group LLC lifted its stake in shares of Intuitive Surgical by 12.0% in the first quarter. Chicago Partners Investment Group LLC now owns 3,873 shares of the medical equipment provider’s stock worth $1,873,000 after buying an additional 415 shares in the last quarter. J. Safra Sarasin Holding AG grew its holdings in shares of Intuitive Surgical by 18.8% during the first quarter. J. Safra Sarasin Holding AG now owns 30,210 shares of the medical equipment provider’s stock valued at $13,910,000 after buying an additional 4,787 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its holdings in shares of Intuitive Surgical by 72.6% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 48,214 shares of the medical equipment provider’s stock valued at $22,226,000 after buying an additional 20,280 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.1%

Shares of ISRG stock opened at $407.12 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $396.68 and a 12-month high of $603.88. The stock has a market capitalization of $144.19 billion, a P/E ratio of 49.35, a P/E/G ratio of 3.31 and a beta of 1.46. The firm’s 50 day moving average is $421.09 and its 200 day moving average is $472.71.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.81 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This represents a 6.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. UBS Group decreased their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday. Mizuho set a $525.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Monday, April 13th. Finally, JPMorgan Chase & Co. lowered their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $562.12.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen kept a Buy rating on Intuitive Surgical while trimming its price target from $585 to $520, signaling that the analyst still sees upside despite a more conservative valuation view. TD Cowen lowers ISRG price target to $520
• Positive Sentiment: Royal Bank of Canada also lowered its target, from $650 to $600, but maintained an Outperform rating, reinforcing a constructive outlook ahead of earnings. RBC lowers ISRG price target to $600
• Positive Sentiment: Multiple articles highlighted Intuitive Surgical as a leading robotics and automation name for the second half of 2026, with investors viewing the company as a beneficiary of AI-enabled surgical robotics growth. Zacks robotics stock list mentions ISRG
• Positive Sentiment: Bearish recent performance has made the stock look more attractive to some analysts, with coverage pieces arguing ISRG could offer roughly 35% upside before earnings if management confirms solid demand and margins. 247WallSt ISRG upside article
• Neutral Sentiment: Intuitive Surgical is expected to report second-quarter EPS of about $2.50 on revenue near $2.82 billion after the close on July 16, with investors likely waiting for results and guidance before making a bigger move. ISRG earnings preview
• Negative Sentiment: The main negative takeaway is that both TD Cowen and RBC reduced their price targets, which suggests analysts are becoming a bit more cautious on valuation even while staying bullish overall.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.